Endometriosis and the risks of systemic lupus erythematosus and rheumatoid arthritis in the nurses' health Study II

Annals of the Rheumatic Diseases

Volumn 75, Issue 7, 2016, Pages 1279-1284

  Harris, Holly R ^a,b   Costenbader, Karen H ^a   Mu, Fan ^c   Kvaskoff, Marina ^a,d,e,f,g   Malspeis, Susan ^a   Karlson, Elizabeth W ^a   Missmer, Stacey A ^a,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d INSERM   (France)

^e UNIVERSITÉ PARIS SACLAY   (France)

^f INSTITUT GUSTAVE ROUSSY   (France)

^g QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; ENDOMETRIOSIS; FEMALE; FOLLOW UP; HUMAN; HYSTERECTOMY; INCIDENCE; LAPAROSCOPY; LIFESTYLE; MAJOR CLINICAL STUDY; OVARIECTOMY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; ARTHRITIS, RHEUMATOID; COMPLICATION; LUPUS ERYTHEMATOSUS, SYSTEMIC; NURSE; STATISTICS AND NUMERICAL DATA;

ADULT; ARTHRITIS, RHEUMATOID; ENDOMETRIOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; NURSES; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84940179673     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2015-207704     Document Type: Article

References (50)

1. Lebovic DI, Mueller MD, Taylor RN. Immunobiology of endometriosis. Fertil Steril 2001;75:1-10.
2. Gabriel S. The epidemiology of rheumatoid arthritis. Rheum Dis Clin North Am 2001;27:269-81.
3. Tiniakou E, Costenbader KH, Kriegel MA. Sex-specific environmental influences on the development of autoimmune diseases. Clin Immunol 2013;149:182-91.
4. Masi A, Kaslow R. Sex effects in systemic lupus erythematosus: A clue to pathogenesis. Arthritis Rheum 1978;21:480-4.
5. Costenbader KH, Feskanich D, Stampfer MJ, et al. Reproductive and menopausal factors and risk of systemic lupus erythematosus in women. Arthritis Rheum 2007;56:1251-62.
6. Goemaera S, Ackerman C, Goethals K, et al. Onset of symptoms of rheumatoid arthritis in relation to age, sex and menopausal transition. J Rheumatol 1990;17:1620-2.
7. Lateef A, Petri M. Hormone replacement and contraceptive therapy in autoimmune diseases. J Autoimmun 2012;38:J170-6.
8. Myasoedova E, Crowson CS, Kremers HM, et al. Is the incidence of rheumatoid arthritis rising?: Results from Olmsted County, Minnesota, 1955-2007. Arthritis Rheum 2010;62:1576-82.
9. Tedeschi SK, Bermas B, Costenbader KH. Sexual disparities in the incidence and course of SLE and RA. Clin Immunol 2013;149:211-18.
10. Alviggi C, Carrieri P, Pivonello R, et al. Association of pelvic endometriosis with alopecia universalis, autoimmune thyroiditis and multiple sclerosis. J Endocrinol Invest 2006;29:182-9.
11. Baptist A, Baldwin J. Autoimmune progesterone dermatitis in a patient with endometriosis: case report and review of the literature. Clin Mol Allergy 2004;2:10.
12. Pasoto SG, Abrao MS, Viana VST, et al. Endometriosis and systemic lupus erythematosus: A comparative evaluation of clinical manifestations and serological autoimmune phenomena. Am J Reprod Immunol 2005;53:85-93.
13. Sinaii N, Cleary SD, Ballweg ML, et al. High rates of autoimmune and endocrine disorders, fibromyalgia, chronic fatigue syndrome and atopic diseases among women with endometriosis: A survey analysis. Hum Reprod 2002;17:2715-24.
14. Nielsen NM, Jørgensen KT, Pedersen BV, et al. The co-occurrence of endometriosis with multiple sclerosis, systemic lupus erythematosus and Sjögren syndrome. Hum Reprod 2011;26:1555-9.
15. Solomon CG, Willett WC, Carey VJ, et al. A prospective study of pregravid determinants of gestational diabetes mellitus. JAMA 1997;278:1078-83.
16. Missmer SA, Hankinson SE, Spiegelman D, et al. Incidence of laparoscopically confirmed endometriosis by demographic, anthropometric, and lifestyle factors. Am J Epidemiol 2004;160:784-96.
17. Karlson EW, Sanchez-Guerrero J, Wright EA, et al. A connective tissue disease screening questionnaire for population studies. Ann Epidemiol 1995;5:297-302.
18. Arnett F, Edworthy S, Bloch D, et al. The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
19. Hochberg M. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
20. Tan E, Cohen A, Fries J, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
21. Karlson EW, Mandl LA, Hankinson SE, et al. Do breast-feeding and other reproductive factors influence future risk of rheumatoid arthritis? Results from the Nurses' Health Study. Arthritis Rheum 2004;50:3458-67.
22. Mikuls TR, Cerhan JR, Criswell LA, et al. Coffee, tea, and caffeine consumption and risk of rheumatoid arthritis: Results from the Iowa Women's Health Study. Arthritis Rheum 2002;46:83-91.
23. MacKinnon D, Fairchild A, Fritz M. Mediation analysis. Annu Rev Psychol 2007;58:593-614.
24. Van der Weele T. Causal mediation analysis with survival data. Epidemiology 2011;22:582-5.
25. Matorras R, Ocerin I, Unamuno M, et al. Prevalence of endometriosis in women with systemic lupus erythematosus and Sjögren's syndrome. Lupus 2007;16:736-40.
26. Nothnick WB. Treating endometriosis as an autoimmune disease. Fertil Steril 2001;76:223-31.
27. Eisenberg VH, Zolti M, Soriano D. Is there an association between autoimmunity and endometriosis? Autoimmun Rev 2012;11:806-14.
28. Simard JF, Costenbader KH. What can epidemiology tell us about systemic lupus erythematosus? Int J Clin Pract 2007;61:1170-80.
29. Shlomchik MJ, Craft JE, Mamula MJ. From T to B and back again: positive feedback in systemic autoimmune disease. Nat Rev Immunol 2001;1:147-53.
30. Aggarwal R, Liao K, Nair R, et al. Anti-citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis. Arthritis Care Res 2009;61:1472-83.
31. Arkema E, Goldstein B, Robinson W, et al. Anti-citrullinated peptide autoantibodies, human leukocyte antigen shared epitope and risk of future rheumatoid arthritis: A nested case-control study. Arthritis Res Ther 2013;15:R159.
32. Heinlen LD, McClain MT, Merrill J, et al. Clinical criteria for systemic lupus erythematosus precede diagnosis, and associated autoantibodies are present before clinical symptoms. Arthritis Rheum 2007;56:2344-51.
33. Hollingsworth P, Pummer S, Dawkins R. Antinuclear antibodies. In: Peter J, Schoenfeld Y, eds. Autoantibodies. Amsterdam: Elsevier Science BV, 1996:74-90.
34. Gleicher N, el-Roeiy A, Confino E, et al. Is endometriosis and autoimmune disease? Obstet Gynecol 1987;70:115-22.
35. Agic A, Xu H, Finas D, et al. Is endometriosis associated with systemic subclinical inflammation? Gynecol Obstet Invest 2006;62:139-47.
36. Akoum A, Al-Akoum M, Lemay A, et al. Imbalance in the peritoneal levels of interleukin 1 and its decoy inhibitory receptor type II in endometriosis women with infertility and pelvic pain. Fertil Steril 2008;89:1618-24.
37. Bedaiwy MA, Falcone T, Sharma RK, et al. Prediction of endometriosis with serum and peritoneal fluid markers: A prospective controlled trial. Hum Reprod 2002;17:426-31.
38. Koumantakis E, Matalliotakis I, Neonaki M, et al. Soluble serum interleukin-2 receptor, interleukin-6 and interleukin-1a in patients with endometriosis and in controls. Arch Gynecol Obstet 1994;255:107-12.
39. Mori H, Sawairi M, Nakagawa M, et al. Peritoneal fluid interleukin-1 beta and tumor necrosis factor in patients with benign gynecologic disease. Am J Reprod Immunol 1991;26:62-7.
40. Pizzo A, Salmeri F, Ardita F, et al. Behaviour of cytokine levels in serum and peritoneal fluid of women with endometriosis. Gynecol Obstet Invest 2002;54:82-7.
41. Wu MH, Yang BC, Hsu CC, et al. The expression of soluble intercellular adhesion molecule-1 in endometriosis. Fertil Steril 1998;70:1139-42.
42. Eriksson C, Rantapää-Dahlqvist S. Cytokines in relation to autoantibodies before onset of symptoms for systemic lupus erythematosus. Lupus 2014;23:691-6.
43. Karlson EW, Chibnik LB, Tworoger SS, et al. Biomarkers of inflammation and development of rheumatoid arthritis in women from two prospective cohort studies. Arthritis Rheum 2009;60:641-52.
44. Bulun SE. Endometriosis. N Engl J Med 2009;360:268-79.
45. Karlson EW, Deane K. Environmental and gene-environment interactions and risk of rheumatoid arthritis. Rheumatic Dis Clin North Am 2012;38:405-26.
46. Lahiri M, Morgan C, Symmons DPM, et al. Modifiable risk factors for RA: prevention, better than cure? Rheumatology 2012;51:499-512.
47. Bengtsson C, Malspeis S, Orellana C, et al. Post-menopausal factors and risk of seropositive and seronegative rheumatoid arthritis phenotypes: Results from the Nurses' Health Study. Boston, MA: American College of Rheumatology, 2014.
48. Johnson NP, Hummelshoj L, World Endometriosis Society Montpellier Consortium. Consensus on current management of endometriosis. Hum Reprod 2013;28:1552-68.
49. Merola J, Bermas B, Lu B, et al. Clinical manifestations and survival among adults with (SLE) according to age at diagnosis. Lupus 2014;23:778-84.
50. Nnoaham KE, Hummelshoj L, Webster P, et al. Impact of endometriosis on quality of life and work productivity: A multicenter study across ten countries. Fertil Steril 2011;96:366-73.e8.